Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 20.62 Billion 17.58 Billion 16.24 Billion 11.83 Billion 7.23 Billion 6.11 Billion
Total Current Assets 13.42 Billion 11.5 Billion 11.55 Billion 9.46 Billion 5.45 Billion 4.68 Billion
Cash And Short Term Investments 10.11 Billion 8.26 Billion 7.94 Billion 8.04 Billion 4.69 Billion 4.52 Billion
Cash and Cash Equivalents 2.74 Billion 1.01 Billion 1.35 Billion 1.27 Billion 2.42 Billion 4.52 Billion
Short Term Investments 7.37 Billion 7.24 Billion 6.58 Billion 6.77 Billion 2.26 Billion 82.31 Million
Net Receivables 1 Billion 575.26 Million 968.4 Million 475.37 Million 250.03 Million 7.5 Million
Inventory 968.08 Million 1.42 Billion 1.34 Billion 705.65 Million 358.59 Million 66.12 Million
Other Current Assets 484.37 Million 339.73 Million 858.1 Million 521.81 Million 614.14 Million 14.97 Million
Total Non-Current Assets 7.19 Billion 6.08 Billion 4.69 Billion 2.36 Billion 1.77 Billion 1.42 Billion
Net PPE 4.85 Billion 4.06 Billion 3.37 Billion 2.18 Billion 1.52 Billion 1.12 Billion
Good Will And Intangible Assets 1.27 Billion 1.19 Billion 772.19 Million 32.62 Million - 52.84 Million
Good Will - - - - - -
Intangible Assets 1.27 Billion 1.19 Billion 772.19 Million 32.62 Million - 52.84 Million
Long-Term Investments 794.08 Million 713.21 Million -6.16 Billion -6.75 Billion -2.26 Billion -
Tax Assets -195.51 Million - - - - -
Other Non Current Assets 478.63 Million 110.03 Million 6.7 Billion 6.91 Billion 2.52 Billion 250.3 Million
Other Assets - - - - - -
Total Liabilities 8.09 Billion 6.85 Billion 5.91 Billion 3.05 Billion 2.47 Billion 1.91 Billion
Total Current Liabilities 4.47 Billion 3.49 Billion 3.05 Billion 1.48 Billion 1.04 Billion 670.32 Million
Account Payables 372.54 Million 325.62 Million 195.05 Million 120.62 Million 84.27 Million 42.82 Million
Tax Payables 194.04 Million 61.01 Million 92.77 Million 5.68 Million 1.75 Million 1.08 Million
Short Term Debt 1.22 Billion 914.39 Million 387.27 Million 271.15 Million 32.55 Million 10 Million
Deferred Revenue -25.17 Million - - - - -96.85 Million
Other Current Liabilities 2.9 Billion 2.25 Billion 2.46 Billion 1.09 Billion 926.73 Million 714.35 Million
Total Non Current Liabilities 3.62 Billion 3.35 Billion 2.86 Billion 1.56 Billion 1.43 Billion 1.24 Billion
Long-Term Debt 2.4 Billion 2.31 Billion 2.1 Billion 935.41 Million 832.53 Million 782 Million
Deferred Revenue Non Current 960.05 Million 883.27 Million 753.27 Million 633.96 Million 598.3 Million 465.84 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.22 Billion 162.3 Million 342 Thousand -925.17 Million 16.51 Million 15.95 Million
Other Liabilities - - - - - -
Total Equity 12.52 Billion 10.72 Billion 10.33 Billion 8.77 Billion 4.75 Billion 4.19 Billion
Stock Holders Equity 12.52 Billion 10.72 Billion 10.33 Billion 8.77 Billion 4.75 Billion 4.19 Billion
Common Stock 112 Thousand 105 Thousand 101 Thousand 97 Thousand 87 Thousand 79 Thousand
Retained Earnings -15.76 Billion -16.68 Billion -12.56 Billion -9.98 Billion -8.98 Billion -8.26 Billion
Accumulated other comprehensive income 12.52 Billion 763.86 Million 397.02 Million 220.41 Million -145.65 Million -293.28 Million
Common Stock Equity 12.52 Billion 10.72 Billion 10.33 Billion 8.77 Billion 4.75 Billion 4.19 Billion
Capital Lease Obligation 98.59 Million 125.07 Million 108.66 Million 26.39 Million 40.08 Million -
Total Investments 794.08 Million 630.19 Million 417.25 Million 12.94 Million 1.98 Million 82.31 Million
Total Debt 3.62 Billion 3.22 Billion 2.49 Billion 1.2 Billion 865.08 Million 792 Million
Net Debt 874.83 Million 2.21 Billion 1.13 Billion -69.61 Million -1.56 Billion -3.73 Billion

Balance Sheet Charts